Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 1, 2012, Pages 43-51

  Lee, Yi Tzu ^a,b,c   Fung, Chang Phone ^b,c   Wang, Fu Der ^b,c   Chen, Chien Pei ^b   Chen, Te Li ^b,c   Cho, Wen Long ^c,d  

^a Chutung Veterans Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

Identification; IS1008; ISAba1; OXA 51; OXA 58

Indexed keywords

CARBAPENEMASE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; ENVIRONMENT; EPIDEMIC; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MOLECULAR EPIDEMIOLOGY; PNEUMONIA; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; URINARY TRACT INFECTION; WOUND INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CLUSTER ANALYSIS; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; ENVIRONMENTAL MICROBIOLOGY; FEMALE; GENES, BACTERIAL; GENETIC VARIATION; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; TAIWAN;

EID: 84856286892     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.09.020     Document Type: Article

References (39)

1. Bergogne-Berezin E., Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996, 9:148-1465.
2. Lee J.H., Choi C.H., Kang H.Y., Lee J.Y., Kim J., Lee Y.C., et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Antimicrob Chemother 2007, 59:633-639.
3. Idzenga D., Schouten M.A., van Zanten A.R. Outbreak of Acinetobacter genomic species 3 in a Dutch intensive care unit. JHosp Infect 2006, 63:485-487.
4. van Dessel H., Kamp-Hopmans T.E., Fluit A.C., Brisse S., de Smet A.M., Dijkshoorn L., et al. Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J Hosp Infect 2002, 51:89-95.
5. Shelburne S.A., Singh K.V., White A.C., Byrne L., Carmer A., Austin C., et al. Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston. Texas. J Clin Microbiol 2008, 46:198-205.
6. Valenzuela J.K., Thomas L., Partridge S.R., van der Reijden T., Dijkshoorn L., Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. JClin Microbiol 2007, 45:453-460.
7. Marchaim D., Navon-Venezia S., Leavitt A., Chmelnitsky I., Schwaber M.J., Carmeli Y. Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital. Infect Control Hosp Epidemiol 2007, 28:945-950.
8. Pournaras S., Markogiannakis A., Ikonomidis A., Kondyli L., Bethimouti K., Maniatis A.N., et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. JAntimicrob Chemother 2006, 57:557-561.
9. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
10. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
11. Walther-Rasmussen J., Hoiby N. OXA-type carbapenemases. JAntimicrob Chemother 2006, 57:373-383.
12. OXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:1530-1533.
13. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 2006, 50:1442-1448.
14. OXA-66 oxacillinase gene. Antimicrob Agents Chemother 2009, 53:2657-2659.
15. OXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9. Antimicrob Agents Chemother 2009, 53:4045-4047.
16. Walsh T.R., Toleman M.A., Poirel L., Nordmann P. Metallo-beta-lactamases: the quiet before the storm?. Clin Microbiol Rev 2005, 18:306-325.
17. Lee Y.T., Huang L.Y., Chiang D.H., Chen C.P., Chen T.L., Wang F.D., et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents 2009, 34:580-584.
18. Chan P.C., Huang L.M., Lin H.C., Chang L.Y., Chen M.L., Lu C.Y., et al. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2007, 28:423-429.
19. Gaynes R.P., Horan T.C. Surveillance of nosocomial infections. Hospital epidemiology and infection control 2004, 1659-1702. Lippincott Williams & Wilkins, Philadelphia. 3rd ed. C.G. Mayhall (Ed.).
20. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
21. Vincent J.L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800.
22. Chen T.L., Siu L.K., Wu R.C., Shaio M.F., Huang L.Y., Fung C.P., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007, 13:801-806.
23. Chang H.C., Wei Y.F., Dijkshoorn L., Vaneechoutte M., Tang C.T., Chang T.C. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. JClin Microbiol 2005, 43:1632-1639.
24. Performance standards for antimicrobial susceptibility testing 2008, Clinical and Laboratory Standards Institute, 18th informational supplement; M100-S18, CLSI, Wayne, PA.
25. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
26. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
27. OXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob Agents Chemother 2008, 52:2573-2580.
28. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
29. GIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob Agents Chemother 2004, 48:4654-4661.
30. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005, 49:4485-4491.
31. Lu P.L., Huang L.Y., Lian S.T., Chang K., Lin C.L., Hwang I.J., et al. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. Int J Antimicrob Agents 2008, 31:463-466.
32. Pasteran F., Rapoport M., Petroni A., Faccone D., Corso A., Galas M., et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 2006, 50:3222-3224.
33. Turton J.F., Gabriel S.N., Valderrey C., Kaufmann M.E., Pitt T.L. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007, 13:807-8015.
34. del Mar Tomas M., Cartelle M., Pertega S., Beceiro A., Llinares P., Canle D., et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 2005, 11:540-546.
35. Tsai H.T., Wang J.T., Chen C.J., Chang S.C. Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units. Diagn Microbiol Infect Dis 2008, 62:298-305.
36. Lin Y.C., Hsia K.C., Chen Y.C., Sheng W.H., Chang S.C., Liao M.H., et al. Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob Agents Chemother 2010, 54:2078-2084.
37. OXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in Acinetobacter genomic species 13TU. Antimicrob Agents Chemother 2010, 54:3107-3112.
38. Poirel L., Marque S., Heritier C., Segonds C., Chabanon G., Nordmann P. OXA-58, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2005, 49:202-208.
39. Marti S., Sanchez-Cespedes J., Blasco M.D., Espinal P., Ruiz M., Alba V., et al. Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate. Diagn Microbiol Infect Dis 2008, 61:468-470.